Metabolic syndrome (MetS) Metabolic syndrome, multisensory based programme, psychological well-being, occupational therapy
Conditions
Interventions
12 weeks multisensory home-based programme, 60 minute per session, 3 session per week (1 group based weekly session with occupational therapist and 2 home-based sessions) ,N/A
Experimental Procedure/Surgery,No Intervention No treatment
Multisensory Home-based Programme,No treatment
Sponsors
Faculty of Associated Medical Sciences, Chaing Mai University
Eligibility
Sex/Gender
All
Age
35 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. people who have three or more of the risk factors as defined by Harmonized criteria of MetS (Alberti et al., 2009), including elevated FPG at least 100 mg/dL or drug treatment of elevated glucose, elevated BP at least 130/85 mmHg or antihypertensive drug treatment, reduced HDL-C less than 40 mg/dL in male or 50 mg/dL in female or drug treatment for reduced HDL-C, elevated at least TG 150 mg/dL or drug treatment for elevated triglycerides, or WC at least 90 cm in male, at least 80 cm in female, 2. People who live in Nam Phrae sub-district, Hang Dong District, Chiang-Mai Province, 3. People with moderate to very high levels of stress as screened by using the Srithanya stress scale, 4. People who can communicate in the Thai language, 5. People who is willing to participate in this study and agree to sign an informed consent form
Exclusion criteria
Exclusion criteria: 1. People who have been diagnosed with sensory impairment by a physician, 2.People who have been diagnosed with thyroid, respiratory, liver, kidney, or cardiovascular diseases by a physician, 3. People with history of serious mental illness, including depression, schizophrenia, bipolar disorder, anxiety disorder, and other psychotic disorders, 4. People with cognitive impairment, 5. People who receive drug treatment that will affect cortisol levels, including cushing drugs, antidepressant, antipsychotic, anti-anxiety, dopamine agents, opiod or antiopioids, drugs of abuse, hormones, rosiglitazone and pioglitazone
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Stress at 12 weeks after end of the intervention Thai Stress Test,Blood cortisol levels at 12 weeks after end of the intervention Morning blood cortisol testing | — |
Secondary
| Measure | Time frame |
|---|---|
| Happiness at 12 weeks after end of the intervention Thai Happiness Indicators (THI-15),Psychological well being at 12 weeks after end of the intervention Group based semi-structured interview ,Fasting blood glucose at 12 weeks after end of the intervention Fasting blood testing ,Systolic and diastolic blood pressure at 12 weeks after end of the intervention Using an autonomic sphygmomanometer,Triglyceride at 12 weeks after end of the intervention fasting blood testing,Total cholesterol at 12 weeks after end of the intervention Fasting blood testing | — |
Countries
Thailand
Contacts
Public ContactIlada Pomngen
Faculty of Associated Medical Sciences, Chaing Mai University
Outcome results
None listed